Cargando…
Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma
PURPOSE: The present study aimed to compare the outcomes of combined phacoemulsification and 360-degree endocyclophotocoagulation with and without goniotomy using a Kahook Dual Blade in patients with glaucoma. PATIENTS AND METHODS: We enrolled 37 patients, 21 of whom underwent combined phacoemulsifi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797312/ https://www.ncbi.nlm.nih.gov/pubmed/33442227 http://dx.doi.org/10.2147/OPTH.S282440 |
_version_ | 1783634841232736256 |
---|---|
author | Izquierdo, Juan Carlos Agudelo, Natalia Rubio, Bárbara Camargo, Jorge Ruiz-Montenegro, Katia Gajardo, Consuelo Rincon, Mirel |
author_facet | Izquierdo, Juan Carlos Agudelo, Natalia Rubio, Bárbara Camargo, Jorge Ruiz-Montenegro, Katia Gajardo, Consuelo Rincon, Mirel |
author_sort | Izquierdo, Juan Carlos |
collection | PubMed |
description | PURPOSE: The present study aimed to compare the outcomes of combined phacoemulsification and 360-degree endocyclophotocoagulation with and without goniotomy using a Kahook Dual Blade in patients with glaucoma. PATIENTS AND METHODS: We enrolled 37 patients, 21 of whom underwent combined phacoemulsification with 360-degree endocyclophotocoagulation and goniotomy using a Kahook Dual Blade (tri-modal therapy (T-MT) group). The remaining 16 patients underwent phacoemulsification with endocyclophotocoagulation (bi-modal therapy (B-MT) group). Visual acuity, intraocular pressure, and number of glaucoma medications were recorded before the study and postoperatively on the first day, at week 1, and at 1, 3, 6, 9, and 12 months. Surgical success was defined as an IOP ≤12 mmHg and ≥6 mmHg or an at least 20% reduction in IOP from baseline with (qualified success) or without medications (complete success). RESULTS: Forty-nine eyes were included. Baseline mean IOP was 16.96±3.66 mmHg and 15.64±4.88 mmHg in the T-MT and B-MT groups (p=0.122), respectively. At the 12-month follow-up, mean IOP values were 11.44±2.15 mmHg and 12.45±1.90 mmHg (p=0.031) in the T-MT and B-MT groups, respectively. Complete success rates were 37% in the T-MT group and 31% in the B-MT group, while qualified success rates were 74% and 50%, respectively. Glaucoma medications decreased from 2.0±1.4 to 0.8±1.0 (p<0.001) in the T-MT group and from 1.5±1.3 to 1.0±1.5 in the B-MT group (p=0.032). Similar improvements in visual acuity were observed in both groups. Complications were mild and resolved without intervention. CONCLUSION: The tri-modal treatment is safe and may be more effective in reducing IOP and glaucoma medication requirements than bi-modal treatment. |
format | Online Article Text |
id | pubmed-7797312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-77973122021-01-12 Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma Izquierdo, Juan Carlos Agudelo, Natalia Rubio, Bárbara Camargo, Jorge Ruiz-Montenegro, Katia Gajardo, Consuelo Rincon, Mirel Clin Ophthalmol Original Research PURPOSE: The present study aimed to compare the outcomes of combined phacoemulsification and 360-degree endocyclophotocoagulation with and without goniotomy using a Kahook Dual Blade in patients with glaucoma. PATIENTS AND METHODS: We enrolled 37 patients, 21 of whom underwent combined phacoemulsification with 360-degree endocyclophotocoagulation and goniotomy using a Kahook Dual Blade (tri-modal therapy (T-MT) group). The remaining 16 patients underwent phacoemulsification with endocyclophotocoagulation (bi-modal therapy (B-MT) group). Visual acuity, intraocular pressure, and number of glaucoma medications were recorded before the study and postoperatively on the first day, at week 1, and at 1, 3, 6, 9, and 12 months. Surgical success was defined as an IOP ≤12 mmHg and ≥6 mmHg or an at least 20% reduction in IOP from baseline with (qualified success) or without medications (complete success). RESULTS: Forty-nine eyes were included. Baseline mean IOP was 16.96±3.66 mmHg and 15.64±4.88 mmHg in the T-MT and B-MT groups (p=0.122), respectively. At the 12-month follow-up, mean IOP values were 11.44±2.15 mmHg and 12.45±1.90 mmHg (p=0.031) in the T-MT and B-MT groups, respectively. Complete success rates were 37% in the T-MT group and 31% in the B-MT group, while qualified success rates were 74% and 50%, respectively. Glaucoma medications decreased from 2.0±1.4 to 0.8±1.0 (p<0.001) in the T-MT group and from 1.5±1.3 to 1.0±1.5 in the B-MT group (p=0.032). Similar improvements in visual acuity were observed in both groups. Complications were mild and resolved without intervention. CONCLUSION: The tri-modal treatment is safe and may be more effective in reducing IOP and glaucoma medication requirements than bi-modal treatment. Dove 2021-01-06 /pmc/articles/PMC7797312/ /pubmed/33442227 http://dx.doi.org/10.2147/OPTH.S282440 Text en © 2021 Izquierdo et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Izquierdo, Juan Carlos Agudelo, Natalia Rubio, Bárbara Camargo, Jorge Ruiz-Montenegro, Katia Gajardo, Consuelo Rincon, Mirel Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma |
title | Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma |
title_full | Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma |
title_fullStr | Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma |
title_full_unstemmed | Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma |
title_short | Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma |
title_sort | combined phacoemulsification and 360-degree endocyclophotocoagulation with and without a kahook dual blade in patients with primary open-angle glaucoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797312/ https://www.ncbi.nlm.nih.gov/pubmed/33442227 http://dx.doi.org/10.2147/OPTH.S282440 |
work_keys_str_mv | AT izquierdojuancarlos combinedphacoemulsificationand360degreeendocyclophotocoagulationwithandwithoutakahookdualbladeinpatientswithprimaryopenangleglaucoma AT agudelonatalia combinedphacoemulsificationand360degreeendocyclophotocoagulationwithandwithoutakahookdualbladeinpatientswithprimaryopenangleglaucoma AT rubiobarbara combinedphacoemulsificationand360degreeendocyclophotocoagulationwithandwithoutakahookdualbladeinpatientswithprimaryopenangleglaucoma AT camargojorge combinedphacoemulsificationand360degreeendocyclophotocoagulationwithandwithoutakahookdualbladeinpatientswithprimaryopenangleglaucoma AT ruizmontenegrokatia combinedphacoemulsificationand360degreeendocyclophotocoagulationwithandwithoutakahookdualbladeinpatientswithprimaryopenangleglaucoma AT gajardoconsuelo combinedphacoemulsificationand360degreeendocyclophotocoagulationwithandwithoutakahookdualbladeinpatientswithprimaryopenangleglaucoma AT rinconmirel combinedphacoemulsificationand360degreeendocyclophotocoagulationwithandwithoutakahookdualbladeinpatientswithprimaryopenangleglaucoma |